Patents by Inventor William B. Kinlaw, III

William B. Kinlaw, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prognosis and treatment of breast cancer
    Patent number: 8853183
    Abstract: The present invention relates to an antibody which specifically binds a Spot 14 (S14 or THRSP) protein in human breast cancer cells and a method for using the same to predict disease-free survival and select treatment modalities for breast cancer. The present invention is also a method for inducing apoptosis in breast cancer cells by inhibiting the expression or activity of Spot 14. Compositions and methods for treating breast cancer are also provided.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: October 7, 2014
    Assignee: Trustees of Dartmouth College
    Inventor: William B. Kinlaw, III
  • Prognosis and treatment of breast cancer
    Patent number: 8614055
    Abstract: The present invention relates to an antibody which specifically binds a Spot 14 (S14 or THRSP) protein in human breast cancer cells and a method for using the same to predict disease-free survival and select treatment modalities for breast cancer. The present invention is also a method for inducing apoptosis in breast cancer cells by inhibiting the expression or activity of Spot 14. Compositions and methods for treating breast cancer are also provided.
    Type: Grant
    Filed: January 20, 2011
    Date of Patent: December 24, 2013
    Assignee: Trustees of Dartmouth College
    Inventor: William B. Kinlaw, III
  • PROGNOSIS AND TREATMENT OF BREAST CANCER
    Publication number: 20130336983
    Abstract: The present invention relates to an antibody which specifically binds a Spot 14 (S14 or THRSP) protein in human breast cancer cells and a method for using the same to predict disease-free survival and select treatment modalities for breast cancer. The present invention is also a method for inducing apoptosis in breast cancer cells by inhibiting the expression or activity of Spot 14. Compositions and methods for treating breast cancer are also provided.
    Type: Application
    Filed: July 30, 2013
    Publication date: December 19, 2013
    Applicant: Trustees of Dartmouth College
    Inventor: William B. Kinlaw, III
  • Prognosis and Treatment of Breast Cancer
    Publication number: 20110150876
    Abstract: The present invention relates to an antibody which specifically binds a Spot 14 (S14 or THRSP) protein in human breast cancer cells and a method for using the same to predict disease-free survival and select treatment modalities for breast cancer. The present invention is also a method for inducing apoptosis in breast cancer cells by inhibiting the expression or activity of Spot 14. Compositions and methods for treating breast cancer are also provided.
    Type: Application
    Filed: January 20, 2011
    Publication date: June 23, 2011
    Applicant: Trustees of Dartmouth College
    Inventor: William B. Kinlaw, III
  • Prognosis and treatment of breast cancer
    Patent number: 7906294
    Abstract: The present invention relates to an antibody which specifically binds a Spot 14 (S14 or THRSP) protein in human breast cancer cells and a method for using the same to predict disease-free survival and select treatment modalities for breast cancer. The present invention is also a method for inducing apoptosis in breast cancer cells by inhibiting the expression or activity of Spot 14. Compositions and methods for treating breast cancer are also provided.
    Type: Grant
    Filed: May 12, 2006
    Date of Patent: March 15, 2011
    Assignee: Trustees of Dartmouth College
    Inventor: William B. Kinlaw, III
  • Prognosis and Treatment of Breast Cancer
    Publication number: 20090232818
    Abstract: The present invention relates to an antibody which specifically binds a Spot 14 (S14 or THRSP) protein in human breast cancer cells and a method for using the same to predict disease-free survival and select treatment modalities for breast cancer. The present invention is also a method for inducing apoptosis in breast cancer cells by inhibiting the expression or activity of Spot 14. Compositions and methods for treating breast cancer are also provided.
    Type: Application
    Filed: May 12, 2006
    Publication date: September 17, 2009
    Inventor: William B. Kinlaw, III